REGULATED INFORMATION
Nyxoah Reports Second Quarter Financial and Operating Results
FDA Approves Genio® System for U.S. Market; Company Begins Commercial [...] Read more »
REGULATED INFORMATION
Nyxoah Reports Second Quarter Financial and Operating Results
FDA Approves Genio® System for U.S. Market; Company Begins Commercial [...] Read more »
INFORMATIONS RÉGLEMENTÉES
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025
La FDA [...] Read more »